The PhRMA Foundation Board of Directors is pleased to name Amy M. Miller, PhD as the new President of the Foundation. Dr. Miller succeeds Eileen Cannon, who is retiring after 22 years of dedicated service in support of the Foundation’s efforts to invest in innovative research, education, and value-driven health care.
The PhRMA Foundation is pleased to present a new virtual three-part webinar series beginning in September that will be focused on enhancing patient-centricity in value and health technology assessments (V/HTA). Attendees will have the opportunity to hear leading health care economists, health outcomes researchers and patient advocates discuss how best to prioritize patient-centered outcomes and ensure inclusive patient engagement in value assessment research.
The PhRMA Foundation has released its 2020 annual report, highlighting a year of activity that included $3.7 million in funding distributions across 15 programs and awards. The report includes summaries of the ongoing work of the Foundation’s grant recipients, awardees, and supported research institutions.
The PhRMA Foundation has announced the recipients of its 2021 Value Assessment Research Awards. A total of $300,000 was awarded to three teams whose proposals put forward new, innovative strategies for assessing the value of medicines and health care services.
The PhRMA Foundation will offer funding for innovative research proposals in the area of Value Assessment in 2022. The Foundation is seeking proposals to identify and address challenges in research conducted to assess the value of medicines and health care services, with funding levels up to $100,000 for a one-year period.
The PhRMA Foundation has announced the winners of a new Challenge Award aiming to support bold and vital research into how value assessment methods and processes can better consider population diversity and drivers of health disparities.
The PhRMA Foundation has announced the winners of the 2020 Value Assessment Challenge Awards. Designed to encourage innovative approaches to defining and measuring value in health care, this year’s awards focused on how patient-centered outcomes can be better incorporated into health care decision making.
The PhRMA Foundation announced the first recipients of its new funding awards in Drug Discovery and Drug Delivery, designed to support the innovative biopharmaceutical research projects of talented young scientists in the United States. A total of 16 recipients were selected and more than $1 million was awarded.
The PhRMA Foundation has announced a call for proposals from researchers across the country that aim to inspire bold and vital research on how value assessment can better capture evidence regarding diverse populations and drivers of health disparities.
The PhRMA Foundation has released its 2019 annual report, highlighting a year of activity that included updating its mission and priorities, the launch of new funding programs and an expansion of its efforts to improve the effectiveness of value assessment in health care.
The PhRMA Foundation has announced a call for proposals from researchers for its 2020 Value Assessment Challenge Awards, responding to a specific value-related question in health care. This year’s question is focused on patient-centered outcomes. The Foundation will provide more than $80,000 to support scientific papers that advance solutions to the question.
The PhRMA Foundation announced recipients of its 2020 Value Assessment Research Awards. $300,000 was awarded to three teams whose proposals put forward new, innovative strategies for assessing the value of medicines and health care services.
The PhRMA Foundation will offer funding for innovative research proposals in the area of Value Assessment in 2021. The Foundation is seeking proposals to identify and address challenges in research conducted to assess the value of medicines and health care services.
Two new grant-funding opportunities from the PhRMA Foundation will provide substantial support for young researchers with innovative projects in Drug Discovery and Drug Delivery. Funding of up to $100,000 is available.
New and innovative approaches to value assessment that aim to move beyond traditional metrics and better incorporate the patient voice were on display at a conference in Washington, DC. Jointly hosted by the PhRMA Foundation and the National Health Council, The Next Generation of Value Assessment: Including the Patient Voice conference brought together leading health economics researchers and patient advocates to discuss value assessment research.
The PhRMA Foundation has announced a shift in mission that will focus on building a better system of value assessment in U.S. health care -- empowering patients and improving health outcomes and efficiencies – while helping shape a new era of multidisciplinary research and drug development, based strongly in the use of advanced technology and data.
Dr. Josephine Briggs, the newly appointed Interim Executive Director for the Patient-Centered Outcomes Research Institute (PCORI) will keynote the PhRMA Foundation and the National Health Council conference, The Next Generation of Value Assessment: Including the Patient Voice, on November 12, 2019 in Washington, D.C.
The PhRMA Foundation has released its 2018 annual report, which highlights the work of its awards, grant programs, research projects and initiatives. The Foundation provided more than $4 million in 2018 to support 54 awards, grants and fellowships in pharmacology and toxicology, clinical pharmacology, health outcomes, informatics, pharmaceutics, translational medicine and therapeutics, and healthcare value assessment.
The PhRMA Foundation will again be offering funding for innovative research proposals in the area of Value Assessment in 2020. The Foundation is seeking proposals to identify and address challenges in research conducted to assess the value of medicines and health care services. Letters of Intent are due August 1, 2019.
The PhRMA Foundation will again be offering funding for innovative research proposals in the area of Value Assessment in 2020. The Foundation is seeking proposals to identify and address challenges in research conducted to assess the value of medicines and health care services.
(June 25, 2019) The PhRMA Foundation announced today the winners of the 2019 Value Assessment Challenge Awards. Designed to encourage innovative approaches in defining and measuring value in health care, this year’s awards focused on novel proposals to improve value assessment methods that move beyond the quality-adjusted life year (QALY).
Advancement in the area of value assessment in health care took the spotlight in several discussions featured recently at the national conference of the 2019 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in New Orleans.
Progress in a large-scale effort by the PhRMA Foundation to improve health care value-assessment will be highlighted during the national conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) next week in New Orleans. To date, the Foundation has invested $2.8 million to support a variety of value-assessment research efforts, including the establishment of four value-assessment Centers of Excellence.
Noted researchers Jay Goodman, PhD, of Michigan State University and Janice B. Schwartz, MD, of the University of California, San Francisco, have received the PhRMA Foundation’s highest honor – its Award of Excellence – recognizing lifetime professional achievements.
At the Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics (ASPET) in Orlando this week, the PhRMA Foundation announced fourteen recipients of its 2019 grants and fellowships in pharmacology/toxicology.
The PhRMA Foundation will fund two additional national Centers of Excellence as a part of its Value Assessment Initiative – to develop transformative, multi-stakeholder-driven solutions that address challenges in assessing the value of medicines and health care services and ultimately improve patient outcomes and reduce inefficiency.
The PhRMA Foundation announced its call for candidates for the 2019 Value Assessment Challenge Awards, which provide a total of $85,000 to support papers that advance solutions to the following question: What are innovative, patient-centered approaches to contribute to health care value assessment that move beyond the inherent limitations of analyses based on the quality-adjusted life year metric?
The PhRMA Foundation has announced the recipients of $300,000 in funding for research projects that yield new, innovative strategies for assessing the value of medicines and health care services -- while improving patient outcomes and reducing inefficiency in health care.
The PhRMA Foundation awarded more than $6 million over the last two years to more than 100 leaders in scientific research in the United States. The Foundation is proud to announce another successful year supporting innovative research efforts in areas of great importance: Alzheimer’s Disease, Melanoma, Parkinson’s Disease, Schizophrenia, Breast Cancer, Lung Cancer, Leukemia, Ulcerative Colitis, Vascular Disease, and Colorectal Cancer. This year the Foundation also funded two Centers of Excellence in Value Assessment.
The PhRMA Foundation and the Personalized Medicine Coalition (PMC) partnered earlier this year for the 2018 Value Assessment Challenge Awards — designed to encourage innovative approaches in defining and measuring value in health care.
The PhRMA Foundation and the Personalized Medicine Coalition (PMC) have announced the recipients of the 2018 Value Assessment Challenge Awards – designed to encourage innovative approaches in defining and measuring value in health care.
Nonprofit health systems research and consulting organization Altarum and its partner, VBID Health, have launched the Research Consortium for Health Care Value Assessment, a PhRMA Foundation-funded initiative that brings together researchers working in health value to collaborate, share findings, and develop research ideas to help address waste and inefficiency in health care.
The PhRMA Foundation announced today the launch of a new online educational series for medical, nursing and pharmacy schools on safe and effective prescribing, featuring instruction from national experts.
New discoveries and innovations in obstetric pharmacology will be highlighted November 1-2, 2018 during “Obstetric-Fetal Pharmacology: Practical Prescribing and Research Methods Update,” a conference for researchers and clinicians to be held at Northwestern University in Chicago.
The PhRMA Foundation has released its 2017 Annual Report, highlighting the work of its grant awardees and progress on other initiatives and projects. The Foundation awarded more than $3 million last year in funding to support the research projects of early career scientists and to advance important health care initiatives, including improving value in health care. The Foundation provided more than 40 awards, grants and fellowships.
The PhRMA Foundation will be partnering with the Personalized Medicine Coalition (PMC) to offer Value Assessment Challenge Awards in 2018, providing more than $80,000 to support scientific papers that advance solutions to a question: What are potentially transformative strategies and methods to define and measure value at all levels of decision making that are aligned with personalized/precision medicine?
The Journal of Comparative Effectiveness Research (CER) has published three articles highlighting the work and recommendations of a national conference aimed at advancing and improving CER, convened last year by the PhRMA Foundation and the Academy of Managed Care Pharmacy.
The PhRMA Foundation will provide $1.3 million in funding for the development of transformative strategies to better assess the value of medicines and health care services while improving patient outcomes and reducing inefficiency in health care. Funding will establish two national value-assessment Centers of Excellence and support the work of several researchers focused on value-based health care.
The PhRMA Foundation announced today that it will fund new one-year, post-doctoral fellowships for individuals interested in pursuing careers in Regulatory Science. The “Regulatory Science Fellowship within Industry” will provide a $70,000 stipend and place participants in pharmaceutical industry settings, where they will gain hands-on experience working with regulatory science professionals.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right